Your browser doesn't support javascript.
loading
PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma.
Polubothu, Satyamaanasa; Bender, Nicole; Muthiah, Siobhan; Zecchin, Davide; Demetriou, Charalambos; Martin, Sara Barberan; Malhotra, Sony; Travnickova, Jana; Zeng, Zhiqiang; Böhm, Markus; Barbarot, Sebastien; Cottrell, Catherine; Davies, Olivia; Baselga, Eulalia; Burrows, Nigel P; Carmignac, Virginie; Diaz, Joey Santiago; Fink, Christine; Haenssle, Holger A; Happle, Rudolf; Harland, Mark; Majerowski, Jacquelyn; Vabres, Pierre; Vincent, Marie; Newton-Bishop, Julia A; Bishop, D Tim; Siegel, Dawn; Patton, E Elizabeth; Topf, Maya; Rajan, Neil; Drolet, Beth; Kinsler, Veronica A.
Afiliação
  • Polubothu S; Mosaicism and Precision Medicine Laboratory, The Francis Crick Institute, London, United Kingdom; Paediatric Dermatology, Great Ormond Street Hospital, London, United Kingdom; Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Bender N; Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Muthiah S; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Zecchin D; Mosaicism and Precision Medicine Laboratory, The Francis Crick Institute, London, United Kingdom; Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Demetriou C; Mosaicism and Precision Medicine Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Martin SB; Mosaicism and Precision Medicine Laboratory, The Francis Crick Institute, London, United Kingdom; Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Malhotra S; Scientific Computing Department, Science and Technology Facilities Council, Research Complex at Harwell, Harwell Oxford, United Kingdom.
  • Travnickova J; MRC Human Genetics Unit and Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Zeng Z; MRC Human Genetics Unit and Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Böhm M; Department of Dermatology, University of Münster, Münster, Germany.
  • Barbarot S; Department of Dermatology, Centre Hospitalier Universitaire Nantes, Nantes, France.
  • Cottrell C; Institute for Genomic Medicine, Nationwide Childrens' Hospital, Columbus, USA.
  • Davies O; Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Baselga E; Department of Dermatology, SJD Barcelona Children's Hospital, Barcelona, Spain.
  • Burrows NP; Department of Dermatology, Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Carmignac V; Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.
  • Diaz JS; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Cancer Research UK Clinical Centre at Leeds, St James's University Hospital, Leeds, United Kingdom; Department of Statistics, College of Science, Central Luzon State University, Science City of Munoz, Philippines; De
  • Fink C; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
  • Haenssle HA; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
  • Happle R; Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany.
  • Harland M; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Cancer Research UK Clinical Centre at Leeds, St James's University Hospital, Leeds, United Kingdom.
  • Majerowski J; Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Vabres P; Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France; Department of Dermatology, CHU Dijon, Dijon, France.
  • Vincent M; Department of Dermatology, Centre Hospitalier Universitaire Nantes, Nantes, France.
  • Newton-Bishop JA; Division of Haematology and Immunology, Leeds Institute of Medical Research, Leeds, United Kingdom.
  • Bishop DT; Division of Haematology and Immunology, Leeds Institute of Medical Research, Leeds, United Kingdom.
  • Siegel D; Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Patton EE; MRC Human Genetics Unit and Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Topf M; Centre for Structural Systems Biology, Leibniz-Institut für Virologie (LIV) and Universitätsklinikum Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Rajan N; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Drolet B; Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Kinsler VA; Mosaicism and Precision Medicine Laboratory, The Francis Crick Institute, London, United Kingdom; Paediatric Dermatology, Great Ormond Street Hospital, London, United Kingdom; Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, United Kingdom. Electronic address
J Invest Dermatol ; 143(6): 1042-1051.e3, 2023 06.
Article em En | MEDLINE | ID: mdl-36566878

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Neurocutâneas / Lentigo / Melanoma Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Child / Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Neurocutâneas / Lentigo / Melanoma Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Child / Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2023 Tipo de documento: Article